| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | 
|---|---|---|---|---|---|
Gross Sales  | 921.93  | 819.37  | 665.9  | 559.56  | 450.06  | 
Excise Duty  | 0  | 0  | 0  | 0  | 0  | 
Net Sales  | 921.93  | 819.37  | 665.9  | 559.56  | 450.06  | 
Other Operating Income  | 0  | 0  | 0  | 0  | 0  | 
Other Income  | 27.47  | 30.86  | 58.64  | 67.47  | 15.23  | 
Total Income  | 949.4  | 850.23  | 724.54  | 627.03  | 465.29  | 
Total Expenditure  | 804.75  | 708.69  | 589.06  | 506.42  | 421.56  | 
PBIDT  | 144.65  | 141.54  | 135.48  | 120.61  | 43.72  | 
Interest  | 14.54  | 16.35  | 32.23  | 32.01  | 51.34  | 
PBDT  | 130.11  | 125.18  | 103.26  | 88.6  | -7.61  | 
Depreciation  | 34.55  | 33.24  | 54.79  | 87.02  | 108.92  | 
Minority Interest Before NP  | 0  | 0  | 0  | 0  | 0  | 
Tax  | -0.09  | 0.11  | 0  | 0  | 0  | 
Deferred Tax  | -0.1  | -3.23  | 0  | 0  | 0  | 
Reported Profit After Tax  | 95.76  | 95.06  | 48.47  | 1.57  | -116.53  | 
Minority Interest After NP  | 0  | 0  | 0  | 0  | 0  | 
Net Profit after Minority Interest  | 99.66  | 92.17  | 46.32  | -1.95  | -116.53  | 
Extra-ordinary Items  | 0  | 0  | 32.44  | 58.47  | 0  | 
Adjusted Profit After Extra-ordinary item  | 99.66  | 92.17  | 13.88  | -60.42  | -116.53  | 
EPS (Unit Curr.)  | 19.65  | 19.06  | 11.35  | -0.48  | -28.55  | 
Book Value (Unit Curr.)  | 0  | 0  | 0  | 0  | 0  | 
Dividend (%)  | 0  | 0  | 0  | 0  | 0  | 
Equity  | 50.72  | 50.72  | 40.82  | 40.82  | 40.82  | 
Public Shareholding (Number)  | 0  | 0  | 0  | 0  | 0  | 
Public Shareholding (%)  | 0  | 0  | 0  | 0  | 0  | 
Pledged/Encumbered - No. of Shares  | 0  | 0  | 0  | 0  | 0  | 
Pledged/Encumbered - % in Total Promoters Holding  | 0  | 0  | 0  | 0  | 0  | 
Pledged/Encumbered - % in Total Equity  | 0  | 0  | 0  | 0  | 0  | 
Non Encumbered - No. of Shares  | 0  | 0  | 0  | 0  | 0  | 
Non Encumbered - % in Total Promoters Holding  | 0  | 0  | 0  | 0  | 0  | 
Non Encumbered - % in Total Equity  | 0  | 0  | 0  | 0  | 0  | 
PBIDTM(%)  | 15.68  | 17.27  | 20.34  | 21.55  | 9.71  | 
PBDTM(%)  | 14.11  | 15.27  | 15.5  | 15.83  | -1.69  | 
PATM(%)  | 10.38  | 11.6  | 7.27  | 0.28  | -25.89  | 
At around 12.53 PM, Orchid Pharma was trading 5% higher at ₹740.40, against the previous close of ₹705.15 on NSE.
The inspection raised, seven minor observations none related to data integrity, and therefore, the facility remains compliant under stringent regulatory standards.
 IIFL Customer Care Number 
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000  / 7039-050-000
 IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.